NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Eclevar Medtech

Eclevar Medtech

Private
ParisHealthcare & Life Scienceshttps://www.eclevarmedtech.com/en/

Last Round

Grant

Feb 2, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Eclevar Medtech is a clinical research organization (CRO) that provides specialized clinical trial, regulatory compliance, and data management services for medical device and in-vitro diagnostic manufacturers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Compliance

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

contract research organizationCROmedical device consultingclinical trial managementregulatory affairsEU MDR complianceIVDR complianceclinical evaluation reportCERpost-market clinical follow-upPMCFclinical data managementmedtech regulatory serviceselectronic data captureEDCdecentralized clinical trialsDCTmedtech compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eclevar Medtech Comparables

Compare Eclevar Medtech with similar companies based on industry and business-model similarity.

Eclevar Medtech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qserve Group
88%
NAMSA
80%
IQVIA Holdings Inc.
78%

Eclevar Medtech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 2, 2026
Joint VentureOct 1, 2020

Key People

Founding team and executive leadership

Chems H.

Chief Executive Officer, Chairman & CEO

Executive Team

MCh Mark Da Costa

COO & CMO (Cardiovascular Technologies)

Executive Team

Eclevar Medtech Investors

Notable investors and investment history

Eclevar Medtech investors
InvestorRounds
KELESVC Round
ballas investVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2026

    Received grant funding from the European Union.

Eclevar Medtech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Eclevar Medtech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Eclevar Medtech's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range36
Year Founded2018
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.